Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
Master Transcription Regulators02:23

Master Transcription Regulators

6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Transcription Factors02:16

Transcription Factors

75.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA i-motif guided synthesis of a selective telomerase inhibitor.

Chemical communications (Cambridge, England)·2026
Same author

i-Motif, not G-quadruplex, stability regulates insulin expression.

Nucleic acids research·2026
Same author

Correction to "DNA G-Quadruplex and i-Motif Structure Formation Is Interdependent in Human Cells".

Journal of the American Chemical Society·2025
Same author

Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbation.

Nature communications·2025
Same author

Evidence that G-quadruplexes form in pathogenic fungi and represent promising antifungal targets.

EMBO molecular medicine·2025
Same author

Affinity-selected peptide ligands specifically bind i-motif DNA and modulate c-Myc gene expression.

Nucleic acids research·2025
Same journal

Subsonic phase front propagation in martensitic transitions of 1,2,4,5-tetrabromobenzene single crystals.

Communications chemistry·2026
Same journal

msBayesImpute as a versatile framework for addressing missing values in biomedical mass spectrometry proteomics data.

Communications chemistry·2026
Same journal

Statistical insights into the role of HCN-mineral interactions in aqueous aerosols during chemical evolution.

Communications chemistry·2026
Same journal

Molecular ground-state conformation prediction based on the Mamba state space model.

Communications chemistry·2026
Same journal

Machine learning evaluation of structural descriptors for supercooled water.

Communications chemistry·2026
Same journal

Designing multifunctional peroxidases by modifying the heme distal site in myoglobin.

Communications chemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.5K

Modulation of Nrf2 expression by targeting i-motif DNA.

E F Warner1, D Guneri2, M A O'Connell1

  • 1School of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, Norfolk, UK.

Communications Chemistry
|January 6, 2025
PubMed
Summary
This summary is machine-generated.

Researchers identified a DNA structure in the Nrf2 gene promoter. Small molecules targeting this structure can control Nrf2 expression, offering new strategies for cancer therapy.

More Related Videos

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

23.1K
Measurements of Physiological Stress Responses in C. Elegans
10:36

Measurements of Physiological Stress Responses in C. Elegans

Published on: May 21, 2020

13.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.5K
Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

23.1K
Measurements of Physiological Stress Responses in C. Elegans
10:36

Measurements of Physiological Stress Responses in C. Elegans

Published on: May 21, 2020

13.8K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is crucial for cellular detoxification and chemoresistance in cancer.
  • While Nrf2 inducers are known, inhibitors are rare, creating a need for novel regulatory strategies.

Purpose of the Study:

  • To investigate an i-motif DNA structure downstream of the Nrf2 promoter as a potential regulatory element.
  • To identify small molecules that interact with the Nrf2 i-motif and modulate Nrf2 expression.

Main Methods:

  • Characterization of a stable i-motif DNA structure near the Nrf2 gene promoter under physiological conditions.
  • Screening for small molecule ligands that bind to the identified i-motif structure.
  • Assessing the impact of these ligands on Nrf2 mRNA expression in human cancer cells.

Main Results:

  • The Nrf2 i-motif structure was confirmed to be stable under near-physiological conditions.
  • Small molecule ligands targeting the i-motif were identified.
  • One ligand significantly upregulated Nrf2 mRNA, while another reduced it in human cancer cells.

Conclusions:

  • This study demonstrates the first instance of controlling Nrf2 gene expression by targeting DNA structures within its promoter region.
  • Targeting the Nrf2 i-motif with small molecules presents a novel therapeutic approach to enhance cancer treatment responsiveness.